TCT 418: High-Volume Cath Lab Insights: CTCA’s Superior Vessel-Specific Concordance in Noninvasive Ischemia Testing — An 18-Month Tertiary Center Experience in Piraeus, Greece

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Boehringer Ingelheim; Asahi</li></ul>